Bausch & Lomb Corp (BLCO)
Bausch & Lomb Corp (BLCO) from its SEC filings: 2025 revenue $5.1 billion (+6% vs the year before), net margin -7%, free cash flow -$66.0 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Ophthalmic Goods |
| Revenue (2025) | $5.1 billion |
| Revenue growth | +6% |
| Net income | -$360.0 million |
| Net margin | -7.1% |
| Free cash flow | -$66.0 million |
| Diluted EPS | $-1.02 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +9% |
| Cash | $367.0 million |
| Long-term debt | $5.0 billion |
| Share count, 1 year | +1% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.